Swiss stocks - Factors to watch on August 3

Crispr Therapeutics AG

03/08/2026 05:57

ZURICH/GDANSK, Aug 3 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:
      
COMPANY STATEMENTS
HOLCIM AG HOLN.S 
Swiss building materials supplier Holcim HOLN.S said on Sunday it plans to sell its Philippines business to China's Huaxin Building Materials 600801.SS in a deal that could raise at least $807 million.  

NOVARTIS NOVN.S 
FDA approves pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (MHSPC), advancing potential new standard of care across metastatic disease. 

ANALYSTS' VIEWS
COMET HOLDING AG : Berenberg raises target price to CHF 490 from CHF 480
COMET HOLDING AG : JP Morgan raises target price to CHF 565 from CHF 500
BUCHER INDUSTRIES AG : Berenberg cuts target price to CHF 360 from CHF 366


ECONOMY
Swiss July CPI due at 0630 GMT.
Swiss July Manufacturing PMI due at 0730 GMT.
SNB sight deposits due at 0800 GMT. 


 (Reporting by Zurich newsroom and Gdansk newsroom)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS